All In MedTech

Indication · Orthopedic Surgery

Hip osteoarthritis

Devices FDA has cleared or approved since 2000 for hip osteoarthritis, found through the 26 FDA device types (product codes) used for it, plus device trials and research. Also searched as: hip osteoarthritis, hip arthroplasty, hip replacement.

Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov

Devices

1,224 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.

AllPMADe Novo510(k)
  • Ceramax® Ceramic Total Hip System

    DePuy Orthopaedics, Inc. · PMA · Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Ceramic/Metal, Cemented Or Uncemented · newest 2025 · 20 decisions

59 more devices with a free account

Showing the first 60. Narrow by pathway, or open a device type below.

Device trials

Device studies on ClinicalTrials.gov for this condition, any status, newest update first.

Open in Trial Radar
  • Hip Innovation TechnologyNot on our public-company list

    NCT05357378 · 288 participants (planned) · Start Jul 15, 2022 · Primary completion Sep 16, 2030

    Device: Hip Innovation Technology Reverse Hip Replacement System; Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination. · For: Degenerative Joint Disease; Osteoarthritis, Hip; Avascular Necrosis of Hip and 1 more

    Sites: Miami, Florida; Tampa, Florida; Baltimore, Maryland · 6 sites in all

472 more trials with a free account

Device types

FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.

Research

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.